查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574680

2024 年先天性心臟疾病设备全球市场报告

Congenital Heart Defect Devices Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

先天性心臟疾病设备市场规模预计在未来几年将强劲成长。 2028年，这一数字将以7.3%的复合年增长率成长至38.6亿美元。预测期内的预期成长是由于临床试验的增加、老年人口的扩大、先天性心臟疾病盛行率的上升、政府支持和资金的增加以及专科医疗中心的增加。这段时期的主要趋势包括技术进步、数位健康科技的普及、个人化医疗、3D 列印技术和穿戴式装置。

先天性心臟疾病设备市场的成长预计将受到微创手术的增加的推动。这些手术涉及透过小切口或自然身体开口进行手术，使用专门的工具和技术来最大程度地减少创伤并改善康復。促进微创手术增加的因素包括技术进步、患者对微创治疗的偏好、手术技术的提高以及减少恢復时间和併发症的好处。先天性心臟疾病设备在这些手术中发挥重要作用，透过较小的切口和基于导管的方法来实现心臟异常的诊断、治疗和管理。例如，根据美国整形外科医师协会（ASPS）的数据，2022年美国进行了23,672,269例美容微创手术，比前一年成长了7%。微创手术的增加反过来又推动了先天性心臟疾病设备市场的发展。

先天性心臟疾病设备市场的主要参与者致力于开发创新技术，例如经导管治疗方案，以提高先天性心臟疾病干预措施的有效性和安全性。经导管治疗是一种微创手术，不需要进行心臟直视手术，用于治疗各种心臟疾病，包括先天性心臟缺陷。例如，2021年6月，美国医疗设备製造商雅培实验室发布了Amplatzer Piccolo，旨在治疗早产儿先天性心臟疾病。该设备采用先进的材料和适合早产儿脆弱生理的专门设计，并采用微创经导管方法进行精确放置和调整，无需进行心臟直视手术。增强的影像技术可确保早产儿心臟小结构内的精确导航和定位。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球先天性心臟疾病设备市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球先天性心臟疾病设备市场表现：规模与成长，2018-2023
  • 全球先天性心臟疾病设备市场预测：规模与成长，2023-2028，2033F

第六章 市场细分

  • 全球先天性心臟疾病设备市场：依设备类型分類的表现与预测，2018-2023、2023-2028F、2033F
  • 导管
  • 心律调节器
  • 单腔心律调节器
  • 双心腔型心律调节器
  • 双心室心律调节器
  • 无导线心律调节器
  • 植入式心臟整流去颤器
  • 双心室装置
  • 植入式心臟循环记录仪
  • 其他设备类型
  • 全球先天性心臟疾病设备市场：依疾病分类的表现与预测，2018-2023、2023-2028F、2033F
  • 心房中膈缺损症
  • 室间隔缺损
  • 房室间隔缺损
  • 三尖瓣闭锁
  • 动脉干
  • 其他疾病
  • 全球先天性心臟疾病设备市场：最终用户的表现和预测，2018-2023、2023-2028F、2033F
  • 医院
  • 专科诊所
  • 学术研究所
  • 其他最终用户

第 7 章 区域/国家分析

  • 全球先天性心臟疾病设备市场：按地区分類的表现与预测，2018-2023、2023-2028F、2033F
  • 全球先天性心臟疾病设备市场：按国家分類的表现和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 先天性心臟疾病器材市场：竞争格局
  • 先天性心臟疾病设备市场：公司简介
    • Pfizer Inc.
    • Johnson & Johnson
    • AstraZeneca plc.
    • Abbott Laboratories
    • GlaxoSmithKline plc.

第31章 其他大型创新企业

  • Medtronic plc.
  • Philips Healthcare
  • Boston Scientific Corporation
  • WL Gore & Associates Inc.
  • Masimo Corporation
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • MicroPort Scientific Corporation
  • Stereotaxis Inc.
  • Berlin Heart GmbH
  • Ventracor Limited
  • Syncardia Systems LLC
  • On-X Life Technologies Inc.
  • Occlutech Holding AG
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Response Biomedical Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r19841

Congenital heart defect devices are specialized medical instruments and implants designed to address and manage heart abnormalities present from birth. These devices are used to diagnose, treat, and support the heart's function in individuals with congenital heart defects, aiming to restore normal blood flow and enhance cardiac performance.

The primary types of congenital heart defect devices include catheters, pacemakers (single-chamber, dual-chamber, biventricular, and leadless), implantable cardioverter defibrillators, biventricular devices, and implanted cardiac loop recorders. Catheters are slender, flexible tubes inserted into the body for various functions such as diagnostic, therapeutic, or monitoring purposes. These devices are used for different types of congenital defects, including ventricular septal defect, atrioventricular septal defect, tricuspid atresia, truncus arteriosus, and others. They are employed by hospitals, specialty clinics, academic and research institutions, and other healthcare settings.

The congenital heart defect devices market research report is one of a series of new reports from The Business Research Company that provides congenital heart defect devices market statistics, including congenital heart defect devices industry global market size, regional shares, competitors with a congenital heart defect devices market share, detailed congenital heart defect devices market segments, market trends and opportunities, and any further data you may need to thrive in the Congenital heart defect devices industry. This Congenital heart defect devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart defect devices market size has grown strongly in recent years. It will grow from $2.72 billion in 2023 to $2.91 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The expansion during the historical period can be ascribed to heightened healthcare awareness campaigns, a rise in heart defect screening programs, stricter medical device regulations, a growing incidence of congenital heart defects, and an elevated risk of organ failure.

The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $3.86 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth projected for the forecast period can be attributed to a rise in clinical trials, an expanding geriatric population, a higher prevalence of congenital heart defects, increased government support and funding, and a growing number of specialized medical centers. Key trends anticipated during this period include advancements in technology, the proliferation of digital health technologies, personalized medicine, 3D printing technology, and wearable devices.

The growth of the congenital heart defect device market is anticipated to be driven by the rising number of minimally invasive procedures. These procedures involve performing surgeries through small incisions or natural body openings, using specialized tools and techniques to minimize trauma and improve recovery. Factors contributing to the increase in minimally invasive procedures include technological advancements, patient preference for less invasive treatments, enhanced surgical techniques, and the advantages of reduced recovery times and complications. Congenital heart defect devices play a crucial role in these procedures by enabling the diagnosis, treatment, and management of heart abnormalities through smaller incisions or catheter-based approaches. For example, according to the American Society of Plastic Surgeons (ASPS), 23,672,269 cosmetic minimally invasive procedures were performed in the United States in 2022, marking a 7% increase from previous years. This rise in minimally invasive procedures is consequently boosting the congenital heart defect device market.

Key players in the congenital heart defect device market are focusing on developing innovative technologies, such as transcatheter treatment options, to enhance the efficacy and safety of interventions for congenital heart defects. Transcatheter treatment is a minimally invasive procedure used to address various heart conditions, including congenital heart defects, without the need for open-heart surgery. For instance, in June 2021, Abbott Laboratories, a US-based medical device company, introduced the Amplatzer Piccolo, a device designed for treating congenital heart defects in premature infants. This device features advanced materials and a specialized design to suit the delicate physiology of premature babies, employing a minimally invasive transcatheter approach for precise placement and adjustment without open-heart surgery. Enhanced imaging technology ensures accurate navigation and positioning within the tiny structures of a premature baby's heart.

In June 2023, Translumina Therapeutics LLP, an India-based cardiovascular device manufacturer, acquired Wellinq Group Company for an undisclosed sum. This acquisition aims to broaden Translumina's cardiovascular and endovascular solutions portfolio and strengthen its market presence in the Netherlands by integrating Blue Medical Devices' innovative technologies and expertise. Wellinq Group Company, based in the Netherlands, specializes in developing and manufacturing products for treating congenital heart defects.

Major companies operating in the congenital heart defect devices market are Pfizer Inc., Johnson & Johnson, AstraZeneca plc., Abbott Laboratories, GlaxoSmithKline plc., Medtronic plc., Philips Healthcare, Boston Scientific Corporation, W. L. Gore & Associates Inc., Masimo Corporation, Lepu Medical Technology (Beijing) Co. Ltd., MicroPort Scientific Corporation, Stereotaxis Inc., Berlin Heart GmbH, Ventracor Limited, Syncardia Systems LLC, On-X Life Technologies Inc., Occlutech Holding AG, Sahajanand Medical Technologies Pvt. Ltd., Response Biomedical Corporation, Xeltis AG, Procyrion Inc., Heartstitch Inc., Cardia Inc., OSYPKA Medical GmbH

North America was the largest region in the congenital heart defect devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart defect devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congenital heart defect devices market consists of sales of septal occluders, heart valves, patent ductus arteriosus (PDA) devices, and bioprosthetic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Defect Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congenital heart defect devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart defect devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The congenital heart defect devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Catheters; Pacemakers; Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers; Implantable Cardioverter Defibrillators; Biventricular Devices; Implanted Cardiac Loop Recorders; Other Device Types
  • 2) By Defect Type: Atrial Septal Defect; Ventricular Septal Defect; Atrioventricular Septal Defect; Tricuspid Atresia; Truncus Arteriosus; Other Defect Types
  • 3) By End user: Hospitals; Specialty Clinics; Academic And Research Institute; Other End Users
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AstraZeneca plc.; Abbott Laboratories; GlaxoSmithKline plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Congenital Heart Defect Devices Market Characteristics

3. Congenital Heart Defect Devices Market Trends And Strategies

4. Congenital Heart Defect Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Congenital Heart Defect Devices Market Size and Growth

  • 5.1. Global Congenital Heart Defect Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Congenital Heart Defect Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Congenital Heart Defect Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Congenital Heart Defect Devices Market Segmentation

  • 6.1. Global Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Catheters
  • Pacemakers
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers
  • Leadless Pacemakers
  • Implantable Cardioverter Defibrillators
  • Biventricular Devices
  • Implanted Cardiac Loop Recorders
  • Other Device Types
  • 6.2. Global Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Atrial Septal Defect
  • Ventricular Septal Defect
  • Atrioventricular Septal Defect
  • Tricuspid Atresia
  • Truncus Arteriosus
  • Other Defect Types
  • 6.3. Global Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Academic And Research Institute
  • Other End users

7. Congenital Heart Defect Devices Market Regional And Country Analysis

  • 7.1. Global Congenital Heart Defect Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Congenital Heart Defect Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Congenital Heart Defect Devices Market

  • 8.1. Asia-Pacific Congenital Heart Defect Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Congenital Heart Defect Devices Market

  • 9.1. China Congenital Heart Defect Devices Market Overview
  • 9.2. China Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Congenital Heart Defect Devices Market

  • 10.1. India Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Congenital Heart Defect Devices Market

  • 11.1. Japan Congenital Heart Defect Devices Market Overview
  • 11.2. Japan Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Congenital Heart Defect Devices Market

  • 12.1. Australia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Congenital Heart Defect Devices Market

  • 13.1. Indonesia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Congenital Heart Defect Devices Market

  • 14.1. South Korea Congenital Heart Defect Devices Market Overview
  • 14.2. South Korea Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Congenital Heart Defect Devices Market

  • 15.1. Western Europe Congenital Heart Defect Devices Market Overview
  • 15.2. Western Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Congenital Heart Defect Devices Market

  • 16.1. UK Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Congenital Heart Defect Devices Market

  • 17.1. Germany Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Congenital Heart Defect Devices Market

  • 18.1. France Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Congenital Heart Defect Devices Market

  • 19.1. Italy Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Congenital Heart Defect Devices Market

  • 20.1. Spain Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Congenital Heart Defect Devices Market

  • 21.1. Eastern Europe Congenital Heart Defect Devices Market Overview
  • 21.2. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Congenital Heart Defect Devices Market

  • 22.1. Russia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Congenital Heart Defect Devices Market

  • 23.1. North America Congenital Heart Defect Devices Market Overview
  • 23.2. North America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Congenital Heart Defect Devices Market

  • 24.1. USA Congenital Heart Defect Devices Market Overview
  • 24.2. USA Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Congenital Heart Defect Devices Market

  • 25.1. Canada Congenital Heart Defect Devices Market Overview
  • 25.2. Canada Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Congenital Heart Defect Devices Market

  • 26.1. South America Congenital Heart Defect Devices Market Overview
  • 26.2. South America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Congenital Heart Defect Devices Market

  • 27.1. Brazil Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Congenital Heart Defect Devices Market

  • 28.1. Middle East Congenital Heart Defect Devices Market Overview
  • 28.2. Middle East Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Congenital Heart Defect Devices Market

  • 29.1. Africa Congenital Heart Defect Devices Market Overview
  • 29.2. Africa Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Congenital Heart Defect Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Congenital Heart Defect Devices Market Competitive Landscape And Company Profiles

  • 30.1. Congenital Heart Defect Devices Market Competitive Landscape
  • 30.2. Congenital Heart Defect Devices Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AstraZeneca plc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline plc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Congenital Heart Defect Devices Market Other Major And Innovative Companies

  • 31.1. Medtronic plc.
  • 31.2. Philips Healthcare
  • 31.3. Boston Scientific Corporation
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. Masimo Corporation
  • 31.6. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Stereotaxis Inc.
  • 31.9. Berlin Heart GmbH
  • 31.10. Ventracor Limited
  • 31.11. Syncardia Systems LLC
  • 31.12. On-X Life Technologies Inc.
  • 31.13. Occlutech Holding AG
  • 31.14. Sahajanand Medical Technologies Pvt. Ltd.
  • 31.15. Response Biomedical Corporation

32. Global Congenital Heart Defect Devices Market Competitive Benchmarking

33. Global Congenital Heart Defect Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Congenital Heart Defect Devices Market

35. Congenital Heart Defect Devices Market Future Outlook and Potential Analysis

  • 35.1 Congenital Heart Defect Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Congenital Heart Defect Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Congenital Heart Defect Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer